Company Quick10K Filing
View Systems
10-Q 2020-09-30 Filed 2020-12-18
10-Q 2020-06-30 Filed 2020-09-04
10-Q 2020-03-31 Filed 2020-08-24
10-K 2019-12-31 Filed 2020-07-02
10-Q 2019-09-30 Filed 2019-12-09
10-Q 2019-06-30 Filed 2019-08-19
10-Q 2019-03-31 Filed 2019-06-28
10-K 2018-12-31 Filed 2019-06-17
10-Q 2018-09-30 Filed 2018-11-21
10-Q 2018-06-30 Filed 2018-08-28
10-Q 2018-03-31 Filed 2018-05-22
10-K 2017-12-31 Filed 2018-04-17
10-Q 2017-09-30 Filed 2017-11-21
10-Q 2017-06-30 Filed 2017-08-15
10-Q 2017-03-31 Filed 2017-08-04
10-K 2016-12-31 Filed 2017-08-04
10-Q 2016-09-30 Filed 2017-08-04
10-Q 2016-06-30 Filed 2017-08-04
10-K 2016-03-31 Filed 2017-08-03
10-K 2015-12-31 Filed 2017-08-03
10-Q 2015-09-30 Filed 2015-11-23
10-Q 2015-06-30 Filed 2015-08-19
10-Q 2015-03-31 Filed 2015-05-20
10-K 2014-12-31 Filed 2015-04-15
10-Q 2014-09-30 Filed 2014-11-19
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-04-15
10-Q 2013-09-30 Filed 2013-11-19
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-01
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-20
10-Q 2012-03-31 Filed 2012-08-20
10-K 2011-12-31 Filed 2012-08-20
10-Q 2011-09-30 Filed 2011-11-21
10-Q 2011-06-30 Filed 2011-08-09
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-03-10
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-10
10-Q 2010-03-31 Filed 2010-05-14
10-K 2009-12-31 Filed 2010-03-31
8-K 2020-05-14
8-K 2020-03-30
8-K 2019-07-31

View Systems Financials

VSYM Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash2029663107141811135313581312213300032090002900
Accounts Receivable5437478411442266333190466745872759293577444403116
Inventory310816118916714229192524111111111111110
PP&E5448312619161315141097644333322221111000
Assets1,0921,48433231255044630132926217010324619748785644151399121014217110392727
Accounts Payable440783596681577572475358505528401449422167167167
Long-Term Debt2430103100837669715346393225114000053200200226
Liabilities1,4381,8232,2182,1502,0371,9581,8251,7971,5111,4661,7051,5491,4651,5601,6761,6361,6511,6601,7161,8271,8581,9351,9772,0222,1961,1188889548799941,083
Stockholders' Equity-346-339-1,887-1,838-1,487-1,512-1,524-1,468-1,248-1,296-1,603-1,303-1,268-28,949-1,597-1,580-1,607-1,644-1,703-1,818-1,849-1,924-1,967-2,021-2,155-1,100-877-954-840-968-1,056
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue743851122102863386710343901011011007352225625924101174359110
Cost of Revenue221405551210197273557191522263494110864690000
Gross Profit52246-16056159751414067-157186797539421855249163767259110
R&D46
SG&A77881229172116408610097617965753361112613043922664421130
Tax00000000000000
Net Income-245-17-1,393-181-1985358511,4003,408-379-452-193-314-85-194-102-38-75-31-75-44-53-1851,054177-72-127-109
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-1428-15294-138-75-266-306-82-31-54-6-57-38-19-7-90-38-5-3-32-9-33-36-28-38
Cash Investing-00-200
Cash Financing111189844246201246422357115547276-0414142-03265038